#1
|
|||
|
|||
Èììóíîïðîôèëàêòèêà
Childhood and Adolescent Immunization Schedules Revised
Ïåðåñìîòðåíû êàëåíäàðè èììóíèçàöèè äåòåé è ïîäðîñòêîâ ÑØÀ èñòî÷íèê - Pediatrics. 2009;123;189–190 [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Îáíîâëåííûå ðåêîìåíäàöèè íà 2009 ãîä èçäàíû â ÿíâàðñêîì íîìåðå æóðíàëà Pediatrics: "..Ñóùåñòâóþò 3 ðàçäåëà: 1) äëÿ äåòåé îò 0 äî 6 ëåò 2) äëÿ äåòåé 7 - 18 ëåò 3) è äîïîëíèòåëüíàÿ ñõåìà èììóíèçàöèè äåòåé è ïîäðîñòêîâ, êîòîðûå íà÷èíàþò âàêöèíèðîâàòüñÿ ïîçäíî èëè îòñòàþò îò îáùåãî ãðàôèêà.." Òåêóùèå èçìåíåíèÿ âêëþ÷àþò: - Ó äåòåé îò 6 ìåñÿöåâ äî 18 ëåò äîëæíà áûòü åæåãîäíàÿ âàêöèíàöèÿ ïðîòèâ ãðèïïà. Âñå ëþäè, èìåþùèå òåñíûå êîíòàêòû ñ äåòüìè âîçðàñòîì îò 0 äî 59 ìåñÿöåâ, òàêæå äîëæíû áûòü ïðèâèòû îò ãðèïïà. Òàêæå è òå ëþäè äîëæíû áûòü ïðèâèòû îò ãðèïïà, êîòîðûå èìåþò òåñíûå êîíòàêòû ñ 5-18 ëåòíèìè äåòüìè, èìåþùèìè çàáîëåâàíèÿ, ïðåäðàñïîëàãàþùèå ýòèõ äåòåé ê îñëîæíåíèÿì ïîñëå ãðèïïà. - Àìåðèêàíñêîå Óïðàâëåíèå ïî êîíòðîëþ çà ïðîäóêòàìè è ëåêàðñòâåííûìè ñðåäñòâàìè (FDA) ëèöåíçèðîâàëî âòîðóþ îðàëüíóþ âàêöèíó ïðîòèâ ðîòàâèðóñíîé èíôåêöèè è îïòèìèçèðîâàëà ñõåìû äîçèðîâàíèÿ äëÿ îáåèõ ðîòàâèðóñíûõ âàêöèí. Ïåðâàÿ äîçà äîëæíà áûòü íàçíà÷åíà äåòÿì âîçðàñòîì îò 6 íåäåëü äî 14 íåäåëü 6 äíåé, è çàêëþ÷èòåëüíàÿ äîçà äîëæíà áûòü äàíà â âîçðàñòå 8 ìåñÿöåâ 0 äíåé. Íå íóæíî íà÷èíàòü èììóíèçàöèþ ïðîòèâ ðîòàâèðóñà äåòÿì âîçðàñòîì îò 15 íåäåëü 0 äíåé è ñòàðøå. |
#2
|
|||
|
|||
Ñèñòåìà ðåãèñòðàöèè ñîîáùåíèé êëèíè÷åñêè ñóùåñòâåííûõ íåáëàãîïðèÿòíûõ ðåàêöèé íà âàêöèíû â ÑØÀ
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#3
|
|||
|
|||
Äåòàëèçèðîâàííûå ðåêîìåíäàöèè ïî îòäåëüíûì âàêöèíàì è ïî èììóíèçàöèè äåòåé ñ ãðóïï ðèñêà (ÑØÀ)
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] èëè â "Êðàñíîé Êíèãå" îíëàéí [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#4
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Vaccines Resource Center îò Medscape òðåáóåòñÿ áåñïëàòíàÿ ðåãèñòðàöèÿ íà Medscape |
#5
|
|||
|
|||
WHO Vaccine Preventable Diseases Monitoring System
Immunization schedules [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Íà ñàéòå ÂÎÇ - êàëåíäàðè èììóíèçàöèè ñòðàí ìèðà. Ìîæíî âûáðàòü ïî ñòðàíå èëè ïî àíòèãåíó. |
#6
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Hot Shots - Vaccines Under The Gun |
#7
|
|||
|
|||
WHO recommendations for routine immunization - summary tables
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#8
|
|||
|
|||
Ñáîðíèê ÂÎÇ "Çäîðîâüå ïóòåøåñòâåííèêîâ-2009"
ðàçäåë ïî èììóíèçàöèè [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#9
|
|||
|
|||
State of the world's vaccines and immunization. Third edition
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] The State of the world's vaccines and immunization (Third edition) is a call to action to governments and donors to sustain and increase funding for immunization in order to build upon the progress made so far in meeting the global goals. It focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals, especially the goal to reduce deaths among children under five. It looks at the development and use of vaccines and at the safeguards that have been put in place to ensure their safety, efficacy, and quality. It sets out the progress and challenges in meeting the immunization-related global goals. It discusses both the cost of scaling up immunization coverage to meet these goals, and efforts to ensure that the achievements are sustainable in the long term. Finally, it looks beyond 2015 to likely changes in the immunization landscape. Part 2 describes over 20 vaccine-preventable diseases and reviews progress since 2000 in efforts to protect populations against these diseases through the use of vaccines. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Îñíîâíûå ïîëîæåíèÿ íà ðóññêîì [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |
#10
|
|||
|
|||
General Recommendations on Immunization
Recommendations of the Advisory Committee on Immunization Practices (ACIP) (Morbidity and Mortality Weekly Report December 1, 2006 / Vol. 55 / No. RR-15) [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] CONTENTS Introduction .................................................. ...................... 1 Timing and Spacing of Immunobiologics ............................. 2 Contraindications and Precautions ...................................... 9 Vaccine Administration .................................................. .... 14 Storage and Handling of Immunobiologics ....................... 20 Altered Immunocompetence ............................................. 24 Special Situations .................................................. ............ 29 Vaccination Records .................................................. ........ 36 Reporting Adverse Events after Vaccination ....................... 36 Vaccination Programs .................................................. ...... 38 Vaccine Information Sources ............................................. 39 Acknowledgments .................................................. ........... 40 References .................................................. ...................... 40 Abbreviations Used in This Publication .............................. 46 Definitions Used in This Report ......................................... 46 Continuing Education Activity ......................................... CE-1 |
#11
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
What You Need to Know About Vaccinations and Travel: - Have you scheduled a visit to your doctor or a travel medicine provider? - Are you aware of which types of vaccinations you or those traveling with you may need? - Do you have altered immunocompetence due to illnesses such as diabetes or HIV? - Are you pregnant or breastfeeding? - Are you traveling with infants or children? - If you haven't looked up our health information for destinations, do so now. |
#12
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
National Vaccine Program Office Q and A |
#13
|
|||
|
|||
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
FDA approves Boostrix to prevent tetanus, diphtheria, and pertussis in older people |
#14
|
|||
|
|||
Âàêöèíà ÀàÊÄÑ-ÈÏÂ//PRP~T (Ïåíòàêñèì™): îáçîð 16-ëåòíåãî îïûòà êëèíè÷åñêîãî ïðèìåíåí
Âàêöèíà ÀàÊÄÑ-ÈÏÂ//PRP~T (Ïåíòàêñèì™): îáçîð 16-ëåòíåãî îïûòà êëèíè÷åñêîãî ïðèìåíåíèÿ
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] |